Carbazeran
SIGMA/SML0308 - ≥95% (HPLC)
Synonym: N-Ethyl-carbamic acid 1-
CAS Number: 70724-25-3
Empirical Formula (Hill Notation): C18H24N4O4
Molecular Weight: 360.41
MDL Number: MFCD00867107
Linear Formula: C18H24N4O4
Product Type: Chemical
| assay | ≥95% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C18H24N4O4/c1-4-19-18( |
| InChI key | QJGVXJYGDBSPSJ-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | CCNC(=O)OC1CCN(CC1)c2nncc |
| solubility | DMSO: ≥2 mg/mL at warmed |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Aldehyde oxidase (AO) substrate; inotropic agent and phosphodiesterase inhibitor |
| Biochem/physiol Actions: | Carbazeran is an Aldehyde oxidase (AO) substrate and a phosphodiesterase inhibitor that produces concentration-dependent positive inotropic responses. In humans, the compound is almost completely cleared via 4-hydroxylation to the phthalazinone metabolite by AO. |
| Features and Benefits: | This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| General description: | Carbazeran is usedin the treatment of heart failure. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P310 + P330 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 41106305 |


